Overview

VZV-specific Tissue Resident Memory T-cells After Shingrix Vaccination

Status:
Not yet recruiting
Trial end date:
2024-02-01
Target enrollment:
Participant gender:
Summary
To evaluate the effect of intramuscular RZV vaccine on VZV-specific skin TRM and circulating T-cells
Phase:
Phase 4
Details
Lead Sponsor:
University of Washington
Collaborator:
National Institute on Aging (NIA)